Crossmark

Comment on “Hepatic arterial infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitors for hepatocellular carcinoma with Vp4 portal vein tumor thrombus: a multicenter, propensity-score matching comparative study”

Crossref DOI link: https://doi.org/10.1007/s12072-025-10938-9

Published Online: 2025-10-18

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Yuanbin

Yan, Yuehua https://orcid.org/0009-0004-7219-805X
License Information

Text and Data Mining valid from 2025-10-18

Version of Record valid from 2025-10-18
More Information

Article History

Received: 14 August 2025

Accepted: 5 October 2025

First Online: 18 October 2025

Declarations

:

: Yuanbin Chen and Yuehua Yan declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects.

Document is current

Any future updates will be listed below